Christel Renoux, MD, PhD
Associate Professor
Dr. Christel Renoux is a practicing neurologist from Lyon, France with expertise in multiple sclerosis and stroke as well as an epidemiologist. Following her MSc in Epidemiology from McGill University, she obtained a PhD in Neurosciences (option epidemiology) from Lyon 1 University, France. Moreover, she completed a postdoctoral fellowship with Dr. Suissa in the Department of Epidemiology at McGill University. On August 1st, 2012, she was appointed as an Assistant Professor in the Department of Neurology and Neurosurgery at McGill University and Investigator at the Centre for Clinical Epidemiology at the Jewish General Hospital-Lady Davis Institute. Her research focuses on neuroepidemiology and pharmacoepidemiology mainly in multiple sclerosis and stroke.
Neuroepidemiology, pharmacoepidemiology
Dr. Renoux’s research program focuses on neuroepidemiology and pharmacoepidemiology. Using various large health databases, she evaluates the safety and effectiveness of medications, particularly related to neurological and psychiatric medications and outcomes, while applying advanced epidemiological methods. She also studies the epidemiology of cerebrovascular diseases in terms of risk factors, prevention and treatment. Her research has been funded by various organizations such as the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation, and Parkinson Canada.
Azoulay L, Dell'Aniello S, Simon T, Renoux C, Suissa S. The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost. 2013 Mar 5;109(3):431-9.
Ernst P, Renoux C, Dell'Aniello S, Suissa S. Pramipexole use and the risk of pneumonia. BMC Neurol. 2012 Sep 29;12:113
Renoux C, Dell'Aniello S, Brophy JM, Suissa S. Dopamine agonist use and the risk of heart failure. Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):34-41.